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The parasitic protozoan Entamoeba histolytica relies on a very dynamic cytoskeleton in order to invade and survive
in host tissues. Identification of cytoskeletal elements is key to understanding these processes. Here we present the
characterization of EhLimA, the first LIM protein of E. histolytica. EhLimA consists of a single LIM domain at its
N terminus and exhibits the highest degree of homology with DdLimE from Dictyostelium discoideum. Immunoflu-
orescence localization of EhLimA using anti-EhLimA antibodies revealed that EhLimA is highly concentrated at the
plasma membrane of cells. Silencing or overexpression of the EhLimA gene did not have a significant effect on the
growth or morphology of the parasite. EhLimA associates with the cytoskeleton as demonstrated by the enrichment
of the protein in cytoskeleton fractions as well as in pull-down assays that revealed that cytoskeleton association
involves interaction with actin. EhLimA binding to actin was shown to be dependent on the N-terminal LIM domain
of EhLimA, as removal of even half of the LIM domain resulted in almost complete inhibition of the binding to actin.
We also found that a portion of EhLimA floats to the lower-density regions of a sucrose gradient together with
portions of the Gal-lectin light subunit and actin. Treatment of cells with the cholesterol-sequestering agent
digitonin resulted in increased solubility of EhLimA. These results indicate that in addition to cytoskeletal asso-
ciation, EhLimA may also associate with lipid rafts in the parasite plasma membrane and suggest that EhLimA may
be part of the molecular system connecting the actin cytoskeleton to membrane rafts.
Many cellular functions are dependent on specific protein-
protein interactions. These protein-protein interactions are
governed by a variety of protein binding domains one of which
is the LIM domain. Since first described nearly 2 decades ago
(21, 28, 57), LIM domain-containing proteins have been iden-
tified in a wide range of eukaryotes, including protozoa (16, 30,
45), plants (5, 20, 40), and yeast (Saccharomyces cerevisiae)
(39), stressing the evolutionary importance of these proteins.
In the parasitic protozoan Entamoeba histolytica, a few studies
have revealed the presence of such proteins (17, 36), although
to date, no LIM domain-containing proteins have been char-
acterized in this organism. The name LIM is derived from the
three developmentally regulated transcription factors, LIN-11
of Caenorhabditis elegans (21), Isl1 of rat (28), and MEC-3 of
C. elegans (57) in which the LIM domain was initially identi-
fied. The LIM domain is a cysteine-rich motif consisting of two
zinc finger-like modules and displaying the consensus sequence
CX2CX16-23HX2CX2CX2CX16-21CX2(C/H/D/) (31). This do-
main is found in a variety of different proteins with diverse
functions, including transcription factors and cytoskeleton-as-
sociated proteins, and may be found in association with other
functional domains, such as homeodomains, protein kinase
domains, or other protein binding domains (31, 54). It serves as
a protein binding interface capable of associating with a wide
range of proteins and mediating protein-protein interactions.
The various binding partners of LIM domains influence the
subcellular localization and functions of the LIM proteins. It is
therefore not surprising that LIM domain-containing proteins
have been found to participate in a broad range of biological
processes, including cytoskeleton organization, transcriptional
regulation, development of cell types, and signaling (4, 18, 31).
LIM domain-containing proteins do not form a functional fam-
ily but have been classified into three groups based on the se-
quence relationships among the LIM domains and overall struc-
ture of the proteins. Group 1 proteins are found primarily in the
nucleus and include LIM homeodomain proteins and LIM-only
proteins that are involved in transcriptional regulation. Group 2
proteins are composed primarily of LIM domains and include
members of the cysteine-rich protein family. Group 3 proteins
contain different numbers of LIM domains located at the C ter-
minus and include proteins such as zyxin and paxillin. Group 2
and group 3 proteins are primarily cytoplasmic, and many are
associated with the actin cytoskeleton (18).
In Dictyostelium discoideum, a number of LIM domain-contain-
ing proteins have been characterized (16, 30, 45). The known
similarity between several proteins of this amoeba with those of E.
histolytica prompted us to investigate whether analogous LIM
domain-containing proteins exist in E. histolytica. Here we present
the characterization of the first LIM domain-containing protein in
E. histolytica which we termed E. histolytica LimA (EhLimA)
(NCBI accession XP_656918.1). We show that EhLimA associ-
ates with the actin cytoskeleton and possibly with lipid raft do-
mains in the plasma membrane, suggesting that it may serve to
connect the actin cytoskeleton to membrane rafts.
MATERIALS AND METHODS
Strains and culture conditions. Trophozoites of E. histolytica strain HM-1:
IMSS were grown at 37°C in TYI-S-33 medium (19). Transfection of trophozo-
ites was performed as previously described (24). Transfectants were grown in the
presence of the neomycin derivative G418.
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Cloning of EhLimA cDNA and sequence analysis. The EhLimA gene sequence
was obtained from the E. histolytica Genome Project (35) of The Institute for
Genomic Research (TIGR) and The Wellcome Trust Sanger Institute. The gene
was cloned into the pBluescript II KS vector following PCR amplification using
cDNA as the template and primers A and B (Table 1). These primers were also
used to sequence the gene in both orientations. The sequence obtained was in
complete accordance with the sequence of the gene appearing in the E. histolytica
Genome Project (35).
Sequence analysis of EhLimA was performed using various tools available on
the ExPASy server (www.expasy.ch/tools/). Multiple alignment was performed
using the ClustalW multiple-sequence alignment program (www.ebi.ac.uk
/clustalw/).
Construction of plasmids for overexpression. All plasmid constructs intended
for overexpression were generated using an intermediate plasmid as follows. The
sequence of interest was first cloned into the NcoI and SalI restriction sites of the
pSA21 intermediate plasmid construct (29). The pSA21 plasmid construct con-
taining the sequence of interest was then digested with BamHI and SacI, which
releases a cassette containing the sequence of interest flanked by 5 and 3 actin
regulatory sequences. This cassette was then transferred to the pEhAct-Neo (38)
vector, after removal of its cassette by digestion with BamHI and SacI.
A plasmid containing the full-length EhLimA sequence (438 bp) was first
prepared by PCR amplification using E. histolytica cDNA as the template and
primers C and B (Table 1). This plasmid was then used as the template for
preparing the sequence of interest as described below. N-terminally and C-
terminally FLAG-tagged EhLimA sequences were obtained by PCR amplifica-
tion using the plasmid containing the full-length EhLimA sequence (described
above) as the template. The 24 nucleotides corresponding to the FLAG epitope
(Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) were synthesized as part of either the 5 or
3 primer for N-terminally or C-terminally tagged EhLimA, respectively, and in
such a way that they were introduced into the sequence. For full-length EhLimA
tagged at the N terminus (462 bp), primers D and B (Table 1) were used. For
N-terminus-truncated EhLimA tagged at the N terminus (375 bp), primers E and
B (Table 1) were used. For C-terminus-truncated EhLimA tagged at the N
terminus (327 bp), primers D and F (Table 1) were used. For full-length EhLimA
tagged at the C terminus (465 bp), primers G and H (Table 1) were used.
Construction of a plasmid for transcriptional silencing. Transcriptional si-
lencing of EhLimA was achieved as previously described for other genes (7) in
the G3 strain of E. histolytica that is already silenced in the expression of the E.
histolytica amoebapore gene (Ehap-a) (8). The full-length EhLimA sequence was
obtained by PCR amplification using the plasmid containing the full-length
EhLimA (described above) as the template and primers I and B (Table 1)
containing NcoI and SalI sites, respectively. The 5 upstream segment (473 bp)
of the Ehap-a gene was obtained by PCR amplification using plasmid psAP-1 (7)
as the template and primers J and K (Table 1) containing SacII and NcoI sites,
respectively. Both of these PCR products were digested with NcoI and ligated to
each other with T4 DNA ligase. The ligation product was amplified by PCR using
primers J and B (Table 1). The PCR product obtained was digested with SacII
and SalI and ligated to the 3 Ehactin flanking region that was obtained by
digestion of the pSA21 (29) plasmid with SalI and BamHI. This cassette con-
taining the 5 upstream segment of the Ehap-a gene, the full-length EhLimA
sequence, and the 3 Ehactin flanking region was cloned into the pEhAct-Neo
(38) vector digested at SacII and BamHI. The resulting plasmid was transfected
into the G3 strain, and transfectants were selected as previously described (7).
Reverse transcription-PCR (RT-PCR). Total RNA was prepared using the
TRI reagent RNA isolation kit (Sigma). Five micrograms of total RNA was
reverse transcribed using an oligo(dT) adaptor primer (Table 1, primer N) and
avian myeloblastosis virus reverse transcriptase (Promega) according to the man-
ufacturer’s protocol. The cDNA product was diluted 25 times and used as the
template for subsequent PCRs.
Production and purification of polyclonal antibodies. In order to produce
specific antibodies against EhLimA, the gene was cloned into a pET bacterial
expression vector downstream of the highly expressed bacterial xylanase protein
fused to an amino-terminal hexahistidine tag (a kind gift from Yoav Barak).
EhLimA was amplified by PCR using E. histolytica cDNA as the template and
primers L and M (Table 1). The PCR product obtained was digested with KpnI
and BamHI and cloned into the corresponding sites of the pET vector. The
His-tagged xylanase-EhLimA fusion protein was expressed in Escherichia coli
(Fig. 1A) and purified by affinity chromatography using Ni-nitrilotriacetic acid
agarose (QIAGEN). The purified fusion protein was separated on a polyacryl-
amide gel, and the band representing xylanase-EhLimA was sliced from the gel
and fragmented by passing it repeatedly through a syringe. Two rabbits were
injected five times with 100 g of protein per injection and an interval of 3 weeks
between each injection. For the first injection, the gel was emulsified with com-
plete Freund’s adjuvant, and for the second injection, the gel was emulsified with
incomplete Freund’s adjuvant. For the remaining injections, phosphate-buffered
saline (PBS) was used. Purified anti-EhLimA antibodies were obtained by am-
monium sulfate precipitation followed by passing the antibody mixture through
a column of Sepharose beads (a kind gift from Talia Miron) coupled to the
purified xylanase protein (a kind gift from Yoav Barak). The antixylanase anti-
bodies bound to the column, while the anti-EhLimA antibodies were eluted. The
specificity of the anti-EhLimA antibodies is shown in Fig. 1B. Purified anti-
EhLimA antibodies were divided into aliquots and stored at 20°C until being
utilized for Western blotting and immunofluorescence labeling.
Preparation of protein fractions. Total cell lysates of E. histolytica trophozoites
were obtained by suspending PBS-washed trophozoites in lysis buffer (50 mM
Tris-Cl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease
inhibitors 0.2 mM leupeptin, 5 mM iodoacetamide, 5 mM 1,10-phenanthroline
monohydrate, and 2 mM phenylmethylsulfonyl fluoride) and incubating for 30
min on ice. The lysates were subjected to centrifugation at 13,000  g in a
microcentrifuge at 4°C, and after removal of the supernatant, the pellet was
resuspended in lysis buffer. The protein concentration of each fraction was
determined by the Bradford assay (9), and 5 to 10 g of protein was taken for
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blots.
SDS-PAGE and Western blots. Samples were prepared by the addition of
sample buffer and boiling for 3 min. Samples were separated on a 15% poly-
acrylamide gel under reducing conditions. Gels were either stained for total
protein with GelCode blue stain reagent (Pierce) or blotted onto nitrocellulose
membranes. Membranes were stained for total protein with Ponceau S before
incubation with antibodies. The dilutions of primary antibodies used in this study
were as follows: polyclonal anti-EhLimA, 1:500; monoclonal anti-FLAG, 1:2,000
(Sigma); monoclonal antiactin, 1:1,000 (ICN Biomedicals, Inc.); and polyclonal
FIG. 1. (A) Analysis of the His-tagged xylanase-EhLimA by gel
electrophoresis following expression and purification in E. coli. Lane 1,
total lysate of bacterial cells overexpressing the His-tagged xylanase-
EhLimA fusion protein; lane 2, purified xylanase-EhLimA fusion pro-
tein. (B) A Western blot analysis demonstrating the specificity of the
purified anti-EhLimA antibodies. The purified xylanase-EhLimA fu-
sion protein (lane 1) and a purified glutathione S-transferase (GST)-
EhLimA fusion protein (lane 2) are recognized by the antibodies,
while purified GST (lane 3) is not.
TABLE 1. Primers used for construction of plasmids





















a S, sense; AS, antisense.
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anti-Gal-lectin light subunit, 1:1,000 (3). These were followed by incubations with
either a horseradish peroxidase-conjugated goat anti-rabbit antibody (1:10,000;
Jackson) or a horseradish peroxidase-conjugated goat anti-mouse antibody (1:
5,000; Jackson). Blots were developed with an enhanced chemiluminescence kit
(ECL; Amersham).
Immunofluorescence and confocal microscopy. E. histolytica cells were resus-
pended in warm TYI-S-33 medium, set on coverslips in a petri dish, and left to
adhere for 10 min at 37°C. After removal of the medium, cells were fixed with
prewarmed PBS containing 3.7% formaldehyde (3.7% formaldehyde-PBS) for
30 min. The coverslips were washed with PBS and permeabilized with PBS
containing 0.1% Triton X-100 for 3 min. Coverslips were washed with PBS and
blocked with PBS containing 5% BSA (5% BSA-PBS) for 1 h. Purified polyclonal
anti-EhLimA antibodies were added at a dilution of 1:10 in 5% BSA-PBS and
incubated for 1 h. The coverslips were washed with PBS and incubated for 30 min
with fluorescein isothiocyanate-conjugated goat anti-rabbit antibodies (Sigma) at
a dilution of 1:200 in 5% BSA-PBS. For actin staining, cells were grown over-
night on coverslips and fixed with prewarmed 3.7% paraformaldehyde-PBS.
Blocking was performed for 30 min with 1% BSA-PBS followed by 40 min of
incubation with phalloidin-tetramethyl rhodamine isocyanate (TRITC) (1 mg/
ml; Sigma) at a dilution of 1:200 in 1% BSA-PBS. Coverslips were washed in PBS
and mounted on a glass slide using VECTASHIELD mounting medium
(VECTOR Laboratories). The coverslips were sealed in place with nail polish.
Fluorescent samples were viewed on a confocal laser-scanning microscope using
either a 40 or 60 objective.
Preparation of cytoskeletal fractions. E. histolytica trophozoites were harvested,
washed, resuspended in lysis buffer (60 mM PIPES, 25 mM HEPES, 125 mM KCl,
2 mM MgCl2, 5 mM EGTA, 0.5 mM ATP, pH 7.2, 1% Triton X-100, and protease
inhibitors 0.2 mM leupeptin, 5 mM iodoacetamide, 5 mM 1,10-phenanthroline
monohydrate, and 2 mM phenylmethylsulfonyl fluoride) and incubated for 30 min
on ice. Lysates were centrifuged at 4°C for 15 min at 500  g. The supernatant was
subjected to ultracentrifugation at 4°C for 1 h at 100,000  g. The supernatant, which
contained the cytoplasmic proteins as well as membrane proteins that were solubi-
lized, was transferred to a new tube. The pellet, which contained the cytoskeleton
and associated proteins, as well as other Triton X-100-insoluble proteins, such as
those associated with lipid rafts, was resuspended in the above buffer. The protein
concentration was determined by the Bradford assay (9).
Immunoprecipitation of FLAG-tagged fusion proteins and immunodetection
of actin. E. histolytica cells overexpressing the various FLAG-tagged EhLimA
fusion proteins as well as control cells were lysed, and lysates were centrifuged at
4°C for 10 min at 13,000  g. The supernatants were incubated with anti-FLAG
M2 affinity gel (Sigma) on a roller shaker at 4°C for 2 h. Resin-bound FLAG-
tagged fusion proteins were pelleted, and FLAG-tagged proteins were eluted by
the addition of 0.1 M glycine HCl. Purified FLAG-tagged fusion proteins were
visualized following SDS-PAGE and total protein staining as described above.
SDS-PAGE, followed by immunoblotting with antiactin antibodies as described
above, was performed in order to detect coimmunoprecipitation of actin.
Treatment of cells with methyl--cyclodextrin or digitonin. For cholesterol
depletion, amoeba cells were incubated with either 20 mM methyl--cyclodextrin
or with 0.2% digitonin in PBS for 30 min on ice. Following incubation, cells were
lysed with lysis buffer containing Triton X-100, and soluble and insoluble frac-
tions were obtained as described above.
Sucrose gradient flotation. E. histolytica trophozoites were lysed in 1 ml of cold
morpholineethanesulfonic acid (MES)-buffered saline (25 mM MES, pH 6.5, 150
mM NaCl, 1% Triton X-100, and protease inhibitors 0.2 mM leupeptin, 5 mM
iodoacetamide, 5 mM 1,10-phenanthroline monohydrate, 2 mM phenylmethyl-
sulfonyl fluoride, 1 mM sodium orthovanadate, and 1 mM sodium pyrophos-
phate) and incubated for 30 min on ice. Total cell lysates were adjusted to 40%
sucrose by adding an equal volume of 80% sucrose and placed at the bottom of
an ultracentrifuge tube. A discontinuous sucrose gradient was generated by
overlaying this with 30% sucrose and 5% sucrose. Tubes were centrifuged at 4°C
for 20 h at 260,000  g (39,000 rpm) in an SW41 rotor. Following centrifugation,
12 fractions of 1 ml each were collected from the top of the gradient. Proteins
were precipitated by the addition of trichloroacetic acid. Protein pellets were
resuspended in sample buffer and subjected to SDS-PAGE and immunoblotting
as described above. The percentage of sucrose in each fraction was determined
using a refractometer (Bausch & Lomb).
RESULTS
Cloning and sequence analysis of a LIM domain-containing
protein in E. histolytica. The gene encoding a LIM domain-
containing protein in E. histolytica was cloned, and the corre-
sponding protein was termed EhLimA (NCBI accession no.
XP_656918.1). The sequence of the EhLimA gene is 438 nu-
cleotides in length and codes for a protein of 145 amino acids
with a calculated molecular mass of 16 kDa. Sequencing data
obtained were in complete accordance with the sequence of
the gene that appears in the E. histolytica genome (35). Anal-
ysis of the deduced amino acid sequence of EhLimA revealed
a single LIM domain at its N terminus spanning amino acid
residues 6 to 59 (Fig. 2A). The C terminus of the EhLimA
protein is rich in glutamic acid, and 18 of the 22 glutamic acid
residues are found in the C terminus. EhLimA exhibits the
highest degree of homology (37% identity and 47% similarity)
to DdLimE (Fig. 2B and C), a Dictyostelium discoideum LIM
domain protein that also has a single LIM domain at its N
terminus (45, 48). The LIM domains of EhLimA and DdLimE
are 44% identical. The glycine-rich domain that follows the
FIG. 2. (A) Nucleotide sequence and deduced amino acid se-
quence of EhLimA. The conserved cysteine and histidine residues of
the N-terminal LIM domain are shown (bold letters). The glutamic
acid-rich C terminus of the protein is indicated by brackets. Part of the
repeat motif that appears twice in Dictyostelium DdLimE is under-
lined. (B) Alignment of the EhLimA amino acid sequence with the
amino acid sequences of Dictyostelium DdLimE and LimD. Identical
residues are represented by black boxes, and similar residues are rep-
resented by gray boxes. Sequences were aligned using the ClustalW
multiple-sequence alignment program (www.ebi.ac.uk/clustalw/). Gen-
Bank accession numbers are as follows: EhLimA, XP_656918; Dd-
LimE, U97699; LimD, AF348467. (C) Schematic representation of
EhLimA and Dictyostelium proteins DdLimE and LimD. The single
N-terminal LIM domain present in all proteins is indicated. The glu-
tamic acid-rich region of EhLimA is represented by a white box. The
glycine-rich region (GLY) and coiled-coil region (shaded oval) of
DdLimE are shown.
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LIM domain and the C-terminal coiled-coil region found in
DdLimE are not present in the EhLimA sequence. However,
EhLimA contains part of a repeat motif, ALNAPKK, that
appears twice in DdLimE. EhLimA was also found to be some-
what homologous to Dictyostelium LimD (19% identity and
28% similarity), that also consists of a single LIM domain at its
N terminus (30). Both DdLimE and LimD of Dictyostelium
have been classified with group 2 of LIM domain-containing
proteins. Similarly, we propose that EhLimA be classified with
this group of proteins as well.
Expression of EhLimA in E. histolytica. Transcription of
EhLimA was verified in an RT-PCR analysis of total RNA.
Amplification of a band of the expected size of 438 bp (Fig.
3A) was obtained, indicating that EhLimA is transcribed in E.
histolytica. Protein expression was analyzed in a Western blot
using purified polyclonal antibodies prepared against recom-
binant EhLimA (Fig. 3B). The anti-EhLimA antibodies spe-
cifically recognize four bands around 16 kDa in size in amoeba
total cell lysates.
Transcriptional silencing of the EhLimA gene. Transcrip-
tional silencing of the EhLimA gene was achieved using a
previously published technique generated in our lab (7). This
technique allows us to induce the silencing of a second gene in
the G3 substrain which is already silenced in the amoebapore
gene (Ehap-a) and has an avirulent phenotype. Our aim in
suppressing the expression of the EhLimA protein was to see
whether this will have any effect on parasite growth or mor-
phology. Silencing of EhLimA in the G3 strain was confirmed
by an RT-PCR analysis that revealed an absence of EhLimA
mRNA expression in the EhLimA-silenced amoeba (Fig. 3C).
Similarly, in a Western blot analysis, no protein was detected in
total lysates of the EhLimA-silenced amoeba (Fig. 3D). Silenc-
ing of EhLimA resulted in the absence of all four bands de-
tected with the anti-EhLimA antibodies, indicating that all are
derivatives or specific variants of EhLimA. Silencing was also
confirmed in the localization studies (see below and see Fig. 4).
The growth and morphology of the EhLimA-silenced amoeba
did not appear to be affected.
Cellular localization of EhLimA. The anti-EhLimA antibod-
ies produced against recombinant EhLimA were also used to
determine the cellular localization of EhLimA by indirect immu-
nofluorescence. In almost all cells examined, EhLimA was highly
FIG. 3. mRNA and protein expression of EhLimA. (A) An RT-PCR
analysis of total RNA using primers specific for EhLimA results in am-
plification of a band of the expected size of 438 bp (lane 1). No amplifi-
cation is attained when the reverse transcription reaction is performed
without reverse transcriptase (lane 2). Amplification of actin is shown in
lane 3. (B) Detection of EhLimA in a Western blot analysis of total cell
lysates using purified anti-EhLimA antibodies reveals four bands around
16 kDa. (C) An RT-PCR analysis of total RNA of G3 transfected tro-
phozoites in which EhLimA is transcriptionally silenced (lane 2) and of
nontransfected G3 cells expressing EhLimA (lane 1). Amplification of
EhLimA (lanes I) is attained only with the nontransfected G3 cells but not
with the EhLimA-silenced cells. No amplification is attained when the
reverse transcription reaction is performed without reverse transcriptase
(lanes II). Amplification of actin (lanes III) is attained with both the
nontransfected G3 cells and with the EhLimA-silenced cells. (D) Western
blot analysis of total cell lysates of G3 transfected trophozoites in which
EhLimA is transcriptionally silenced. The anti-EhLimA antibodies do not
detect any protein in these cells (lane 2), whereas the protein is detected
in the nontransfected G3 cells expressing EhLimA (lane 1).
FIG. 4. Immunofluorescence localization of EhLimA in whole parasites. Trophozoites were fixed and stained for immunofluorescence with anti-EhLimA
antibodies followed by fluorescein isothiocyanate-conjugated anti-rabbit secondary antibodies and viewed under a confocal microscope. The differential
interference contrast images are shown on the top, and the corresponding fluorescence images are shown on the bottom. EhLimA localizes mainly to the plasma
membrane of cells (a and b). No staining was detected in the EhLimA-silenced G3 amoeba cells (c). Staining cells with phalloidin-TRITC reveals and enrichment
of actin in the cell cortex and in cellular protrusions (d). Bars, 10 m in panel a and 20 m in panels b, c, and d.
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enriched at the plasma membrane of the cells with some light
staining in the cytoplasm (Fig. 4). A similar staining pattern was
observed with both the parental HM-1:IMSS cells (Fig. 4a) as well
as with the G3 substrain (Fig. 4b). The staining observed was very
specific, as only a very faint signal was detected in the cytoplasm
of the EhLimA-silenced amoeba (Fig. 4c). Amoeba cells were
also stained with phalloidin that stains actin filaments (Fig. 4d).
An enrichment of F-actin at the plasma membrane of cells re-
sulting from staining of the underlying cortical actin was observed.
F-actin was also highly enriched in cellular protrusions.
EhLimA associates with the cytoskeleton and interacts with
actin. Many LIM domain-containing proteins have been shown
to associate with the actin cytoskeleton (31), including the
Dictyostelium homologs DdLimE (45, 48) and LimD (30)
which were found to localize to the cell cortex. Localization of
EhLimA to the plasma membrane led us to examine whether
EhLimA associates with the underlying actin cytoskeleton. The
presence of EhLimA in cytoskeletal fractions was first exam-
ined. Total cell lysates prepared with the addition of Triton
X-100 were subjected to ultracentrifugation, resulting in a pel-
let fraction containing the Triton X-100-insoluble cytoskeleton
and a supernatant fraction containing the soluble proteins.
Proteins from these fractions were separated by SDS-PAGE
followed by Western blotting with anti-EhLimA antibodies
(Fig. 5). The results show that a significant portion of EhLimA
is found in the Triton X-100-insoluble cytoskeleton fraction.
The majority of actin was detected in this fraction, also con-
firming the specificity of this fraction. These results indicate
that EhLimA is associated with the cytoskeleton.
The cytoskeleton association of EhLimA was further exam-
ined by assaying whether actin binding is involved. A construct
was prepared that encoded full-length EhLimA (amino acid
residues 1 to 145) tagged at the N terminus with the 24 nucle-
otides (8 amino acids) corresponding to the FLAG epitope
(FLAG-EhLimA; Fig. 6A, panel a). This construct was cloned
into an amoeba overexpression vector under the control of the
Ehactin gene promoter and transfected into amoeba cells. Pro-
tein expression of FLAG-EhLimA was confirmed by Western
blotting with both anti-EhLimA antibodies as well as anti-
FLAG monoclonal antibodies (Fig. 6B). Interestingly, in
FLAG-EhLimA-overexpressing cells, the anti-EhLimA anti-
bodies detected in addition to the bands representing endog-
enous EhLimA a slightly larger band probably representing the
FLAG-EhLimA fusion protein, while the anti-FLAG antibod-
ies recognized this larger band but no additional bands. The
FIG. 5. EhLimA associates with the cytoskeleton. Total cell lysates
(T) prepared with the addition of Triton X-100 were subjected to
ultracentrifugation resulting in a pellet fraction (P) containing the
Triton X-100-insoluble cytoskeleton and a supernatant fraction
(S) containing soluble proteins. A Western blot analysis of these frac-
tions using anti-EhLimA antibodies shows that a significant portion of
EhLimA is found in the Triton X-100-insoluble cytoskeleton fraction.
Monoclonal antiactin antibodies reveal that the majority of actin is
detected in this fraction as well.
FIG. 6. (A) Schematic representation of constructs encoding full-
length and truncated FLAG-tagged EhLimA. (a) N-terminus-tagged
full-length EhLimA (FLAG-EhLimA); (b) N-terminus-tagged
EhLimA lacking half of the N terminus LIM domain (N-TRUNC); (c)
N-terminus-tagged EhLimA lacking the glutamic acid-rich C terminus
(C-TRUNC); (d) C-terminus-tagged full-length EhLimA (C-FLAG).
(B) Protein expression of FLAG-EhLimA is confirmed in a Western
blot analysis using anti-EhLimA antibodies (lanes I) and anti-FLAG
monoclonal antibodies (lanes II). Lane 1 and 2 contain total cell lysates
of wild-type cells and FLAG-EhLimA-overexpressing cells, respec-
tively. (C) Different amounts of total cell lysates of FLAG-EhLimA-
overexpressing cells (lanes 1 to 3) and wild-type cells (lane 5) were incu-
bated with anti-FLAG monoclonal antibodies covalently attached to
agarose. Immunoprecipitated FLAG-EhLimA was analyzed by gel elec-
trophoresis followed by total protein staining of the gel (top gel). Coim-
munoprecipitation of actin was analyzed in a Western blot of immuno-
precipitated protein products using antiactin antibodies (bottom gel).
Lane 1, 250 g total lysate; lane 2, 100 g total lysate; lane 3, 50 g total
lysate; lane 5, 500 g total lysate. Protein amounts are confirmed in lanes
4 and 6 for FLAG-EhLimA-overexpressing cells and wild-type cells, re-
spectively, each containing 10 g of total lysate.
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FLAG-EhLimA fusion protein was immunoprecipitated from
cells using anti-FLAG monoclonal antibodies covalently at-
tached to agarose. Purified FLAG-EhLimA was analyzed by
SDS-PAGE, followed by total protein staining of the gel (Fig.
6C, top gel). As can be seen, the amount of purified protein
detected in the gel was in direct correlation to the amount of
total cell lysate used in the assay. Immunoprecipitated protein
products were analyzed in a Western blot using antiactin an-
tibodies in order to determine whether actin is coimmunopre-
cipitated together with EhLimA (Fig. 6C, bottom gel). Indeed,
actin was detected in the lanes corresponding to cells overex-
pressing FLAG-EhLimA, and the amount of actin detected
was directly related to the amount of purified FLAG-EhLimA
protein in each lane. No actin was detected in the lane corre-
sponding to wild-type cells. These results clearly show that
EhLimA associates with actin and that this association is spe-
cific. Interestingly, we noticed that while the antiactin antibod-
ies identify two bands in total cell lysates, only the upper band
appears in the lanes containing the purified FLAG-EhLimA
protein. The lower band may represent a degraded form of
actin that does not associate with EhLimA. A smaller actin
fragment was recently identified in a two-dimensional gel elec-
trophoresis analysis of the E. histolytica proteome (34). Taken
together, it is reasonable to assume that plasma membrane
localization of EhLimA is due at least in part to an association
of EhLimA with the underlying cortical actin cytoskeleton.
Actin binding is dependent on the N terminus but not the C
terminus of EhLimA. In order to identify the region of the
protein involved in actin binding, two constructs were prepared
encoding EhLimA truncated at either the N terminus (amino
acid residues 31 to 145) or C terminus (amino acid residues 1
to 100) tagged at the N terminus with the FLAG epitope. The
N-terminus-truncated and FLAG-tagged EhLimA (N-TRUNC)
is lacking half of the LIM domain (Fig. 6A, panel b), while the
C-terminus-truncated FLAG-tagged EhLimA (C-TRUNC) is
lacking the glutamic acid-rich region of the protein (Fig. 6A,
panel c). Both constructs were cloned into an amoeba overex-
pression vector under the control of the Ehactin gene pro-
moter and transfected into amoeba cells. Protein expression of
the truncated FLAG-tagged EhLimA proteins was verified by
Western blotting using anti-FLAG monoclonal antibodies
(Fig. 7A). The truncated proteins were immunoprecipitated
using anti-FLAG antibodies covalently attached to agarose.
PAGE of the immunoprecipitated protein products revealed
nice amounts of both truncated proteins (Fig. 7B, top gel). The
ability of the truncated EhLimA proteins to associate with
actin was verified in a Western blot analysis of immunoprecipi-
tated protein products using antiactin antibodies (Fig. 7B, bot-
tom gel). While the intensity of the band detected in the lane
containing purified C-TRUNC was similar to that of the band
detected in the control lane containing the purified full-length
FLAG-EhLimA fusion protein, a very light band was detected
in the lane containing purified N-TRUNC. These results show
that the association between EhLimA and actin is dependent
on the N terminus of EhLimA, which contains the LIM do-
main, and that removal of even half of the LIM domain sig-
nificantly inhibits the ability of EhLimA to associate with actin.
The C terminus of EhLimA, on the other hand, does not
appear to be involved in actin binding, as removal of this
region of the protein does not affect the ability of the protein
to associate with actin.
N-terminal cleavage of EhLimA. The observation that the
anti-EhLimA antibodies detect four bands in Western blots of
amoeba total cell lysates suggested that this protein undergoes
some type of cleavage or modification resulting in a number of
protein variants. Though we considered the possibility that
these bands were the result of unspecific degradation, the gel
migration pattern of the bands was highly reproducible and
was observed in all Western blots analyzed. In addition, if there
was unspecific degradation, it would most likely also affect
other proteins analyzed and this was not the case. As shown in
Fig. 6B, in FLAG-EhLimA-overexpressing cells, the anti-
EhLimA antibodies detect in addition to these bands, a slightly
larger band representing the FLAG-EhLimA fusion protein.
However, the anti-FLAG antibodies recognize only the
FLAG-EhLimA protein in these cells. The inability of the
anti-FLAG antibodies to recognize any additional bands sug-
FIG. 7. (A) Expression of N-terminus- and C-terminus-truncated
FLAG-tagged EhLimA. Protein expression of N-terminus-truncated
FLAG-tagged EhLimA (N-TRUNC, lane 2) and C-terminus-trun-
cated FLAG-tagged EhLimA (C-TRUNC, lane 3) is confirmed in a
Western blot analysis with anti-FLAG antibodies. In lane 1, expression
of the full-length FLAG-EhLimA fusion protein is shown. Lane 4
contains a total cell lysate of wild-type cells. (B) Immunoprecipitation
and actin binding of N-terminus- and C-terminus-truncated FLAG-
tagged EhLimA. Total cell lysates of cells overexpressing FLAG-
EhLimA (lane 1), N-TRUNC (lane 2), or C-TRUNC (lane 3) and
wild-type cells (lane 4) were incubated with anti-FLAG monoclonal
antibodies covalently attached to agarose. Immunoprecipitated pro-
teins were analyzed by gel electrophoresis, followed by total protein
staining of the gel (top gel). A Western blot analysis of immunopre-
cipitated protein products using antiactin antibodies reveals that N-
TRUNC has almost completely lost the ability to bind actin (bottom
gel). Protein amounts are confirmed in lanes 5 to 8 for lanes 1 to 4,
respectively, each containing 10 g of total lysate. (C) N-terminal
cleavage of EhLimA. Anti-FLAG antibodies detect four bands in a
Western blot of total cell lysates of cells overexpressing FLAG-tagged
full-length EhLimA in which the FLAG epitope is located at the C
terminus of the protein (C-FLAG, lane 2) as opposed to only one band
that is detected in total cell lysates of the N-terminus-tagged FLAG-
EhLimA-overexpressing cells (lane 1).
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gests that these bands are the result of N-terminal cleavage of
EhLimA. Such cleavage would result in removal of the FLAG
epitope that is located at the N terminus of the protein, and
N-terminally cleaved variants of EhLimA would not be de-
tected by the anti-FLAG antibodies. N-terminal cleavage of
EhLimA was further confirmed by overexpressing a construct
encoding full-length EhLimA tagged at the C terminus with
the FLAG epitope (C-FLAG; Fig. 6A, panel d). In lysates of
cells overexpressing C-terminus-tagged full-length EhLimA,
four bands were detected by the anti-FLAG antibodies as
opposed to only one band that is detected in lysates of cells
overexpressing the N-terminus-tagged FLAG-EhLimA fusion
protein (Fig. 7C). Taken together, these data indicate that
EhLimA undergoes N-terminal cleavage.
Evidence that a portion of EhLimA associates with lipid
rafts in the parasite membrane. Lipid rafts are membrane
domains that have been found to play a role in various cellular
functions, including membrane trafficking, endocytosis, secre-
tion, and signal transduction (13, 52, 53). Recently, raft-like
microdomains were identified in E. histolytica and were found
to be involved in pinocytosis and adhesion (33). Insolubility in
Triton X-100, which is a property common to cytoskeleton-
associated proteins, can also serve as an indication that the
protein associates with lipid rafts (25, 49) that are insoluble in
Triton X-100 due to their high cholesterol and sphingolipid
content (14, 52). Insolubility of EhLimA in Triton X-100 was
observed following ultracentrifugation as shown in Fig. 5, or
when cell lysates were fractionated at lower speed centrifuga-
tion (13,000  g) into supernatant (soluble) and pellet (insol-
uble) fractions (Fig. 8A). In this case also, a significant portion
of EhLimA was found in the Triton X-100-insoluble pellet
fraction. Interestingly, a similar distribution of the amoebic
Gal-lectin light subunit (Ehlgl), which was reported to be
present in raft-like fractions (33), was observed in these frac-
tions as well.
The association of EhLimA with lipid rafts was assayed by
sucrose gradient centrifugation, a method commonly used for
isolating lipid rafts (13, 53). Total cell lysates prepared with
cold Triton X-100 were loaded at the bottom of a sucrose
gradient and subjected to sucrose gradient flotation. Fractions
were collected from the top of the gradient, and the distribu-
tion of EhLimA as well as of Ehlgl and actin was analyzed in
the collected fractions by SDS-PAGE followed by immuno-
blotting (Fig. 8B). Following sucrose gradient flotation, a por-
tion of EhLimA was detected in the lower-density regions of
the gradient. EhLimA was also detected in other regions, in-
cluding the high-density regions of the gradient. This was ex-
pected, since we have shown that EhLimA associates with the
actin cytoskeleton that itself distributes to the high-density
regions of the gradient, as seen here by the predominance of
actin in these fractions. Ehlgl, which as already mentioned has
been shown to interact with lipid microdomains in E. histolytica
(33), was used as a marker for raft-like domains and was
indeed found to be enriched in the lower-density regions of the
gradient, though it also appeared in the higher-density regions.
Results obtained in three independent experiments revealed
some differences in the distribution of EhLimA, but in all
experiments, a portion of EhLimA was found in association
with the lower-density regions of the gradient.
Depletion or sequestration of cholesterol from the mem-
brane many times renders raft-associated proteins detergent
soluble as a result of raft disruption. The cholesterol-depleting
agent methyl--cyclodextrin has been shown to increase the
detergent solubility of various raft-associated proteins (32, 47).
Digitonin that disrupts rafts by sequestering membrane sterols
has resulted in increased solubility of a protein associated with
the Triton X-100-insoluble floating fraction in Dictyostelium
(26). Amoeba cells were incubated on ice with either methyl-
-cyclodextrin or digitonin in order to determine whether the
Triton X-100 insolubility of EhLimA is dependent on the pres-
ence of cholesterol. The cells were then lysed with Triton
FIG. 8. A portion of EhLimA associates with lipid rafts. (A) Total
cell lysates prepared with the addition of cold Triton X-100 were
subjected to centrifugation resulting in soluble (S) and insoluble
(P) fractions. A Western blot analysis using anti-EhLimA antibodies
shows that a significant portion of EhLimA is found in the Triton
X-100-insoluble fraction. A similar protein distribution of the amoebic
Gal-lectin light subunit (Ehlgl) was detected using polyclonal anti-
Ehlgl antibodies. (B) Total cell lysates prepared with cold Triton X-100
were subjected to sucrose gradient flotation. Twelve fractions were
collected from the top of the gradient and proteins were precipitated
with trichloroacetic acid. Following SDS-PAGE and immunoblotting,
the distribution of EhLimA, Ehlgl, and actin in the fractions was
analyzed. A portion of EhLimA as well as of Ehlgl and actin was
detected in the lower-density regions of the gradient. The presence of
EhLimA in the lower-density regions was observed in three indepen-
dent experiments. The percentage of sucrose in each fraction is indi-
cated. (C) Depletion of cholesterol. Cells were incubated for 30 min
with either digitonin or methyl--cyclodextrin on ice followed by lysis
in Triton X-100 and centrifugation. Western blotting reveals that the
distribution of EhLimA between soluble (S) and insoluble (P) fractions
was greatly affected by digitonin but not by methyl--cyclodextrin.
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X-100 and fractionated by centrifugation into soluble and in-
soluble fractions (Fig. 8C). Analysis of these fractions revealed
that treatment of cells with methyl--cyclodextrin did not ap-
pear to have any effect on the solubility of EhLimA, as the
distribution of the protein between soluble and insoluble frac-
tions was not affected. Similar results were obtained when
methyl--cyclodextrin-treated cells were incubated at 37°C in-
stead of on ice (not shown). When cells were treated with
digitonin, however, the solubility of EhLimA increased dra-
matically, as most of the protein was detected in the superna-
tant and only a very small amount was detected in the insoluble
pellet. The almost complete solubilization of EhLimA by di-
gitonin indicates that the Triton X-100 insolubility of EhLimA
is due to an association of EhLimA with cholesterol-rich lipid
rafts in the membrane. It has been reported that there are
cases where methyl--cyclodextrin does not solubilize raft-as-
sociated proteins (44). The reason for the lack of solubilization
of EhLimA by methyl--cyclodextrin in E. histolytica tropho-
zoites may also be due to differences in membrane lipid com-
position of this parasite.
DISCUSSION
Various cellular activities, including motility and chemo-
taxis, adhesion, endocytosis, phagocytosis, and cytokinesis, are
dependent on the cytoskeleton of the cell. In order to invade
and survive in host tissues, E. histolytica trophozoites rely on a
highly dynamic cytoskeleton to perform such processes as
phagocytosis, motility, or adhesion that are required for the
pathogenesis of E. histolytica (23). Various components of the
cytoskeleton have been identified in E. histolytica (37), and a
number of proteins have been shown to bind actin, including
myosin IB (56), calcium binding protein 1 (46), and the actin
binding protein ABP-120 (55). In a wide variety of eukaryotic
organisms, LIM domain-containing proteins have been shown
to interact directly or indirectly with the actin cytoskeleton (27,
31). The recent completion of the E. histolytica Genome
Project (35) revealed the presence of several LIM domain-
containing proteins present in the E. histolytica genome. Of
these, 12 are annotated as LIM domain proteins or proteins
containing LIM domains, but the total number of LIM do-
main-containing proteins is apparently higher, as some LIM
domain-containing proteins have been annotated as proteins
to which they are homologous.
Here we have characterized the first LIM domain-containing
protein of E. histolytica which we have termed EhLimA.
EhLimA contains a single LIM domain at its N terminus and
shares the highest degree of homology with the Dictyostelium
DdLimE LIM domain protein. DdLimE localizes to the cell
cortex and regulates cell motility and cytokinesis (45, 48). We
found that EhLimA associates with the cytoskeleton and that
cytoskeleton association involves actin binding. This is shown
by the detection of a significant portion of EhLimA in the
actin-enriched cytoskeleton fraction of cells. In addition, im-
munoprecipitation of a FLAG-EhLimA fusion protein from
cells resulted in coimmunoprecipitation of actin, indicating
that EhLimA is associated with actin. Our results show that the
N-terminal LIM domain of EhLimA is necessary for actin
binding, which is consistent with the role of the LIM domain in
mediating protein-protein interactions. We found that removal
of even half of the LIM domain from the protein almost com-
pletely prevented actin binding. On the other hand, we did not
find that the glutamic acid-rich C terminus plays a role in actin
binding as removal of this region of the protein had no effect
on actin binding.
Our results also suggest a possible association between
EhLimA and raft-like microdomains in the E. histolytica
plasma membrane. First of all, a significant portion of EhLimA
was not solubilized by cold Triton X-100. Triton X-100 insol-
ubility is a property characteristic of cytoskeleton-associated
proteins but may also indicate that the protein associates with
lipid rafts (25, 49). In the case of EhLimA, Triton X-100
insolubility may be the result of associations with both the
cytoskeleton and lipid rafts. Association of EhLimA with lipid
rafts was shown by the distribution of a portion of EhLimA to
the lower-density regions of a sucrose gradient. Since raft-like
microdomains have only recently been identified in E. histo-
lytica (33), at present there is no well-accepted raft marker for
this organism. We used the light subunit of the amoebic Gal-
lectin (Ehlgl) that was shown to interact with lipid microdo-
mains in E. histolytica (33) and found that it was indeed en-
riched in the lower-density regions of the sucrose gradient.
Increased solubility of many raft-associated proteins is
achieved by cholesterol depletion (6, 15, 32, 47). We found that
treatment of cells with the cholesterol-depleting agent methyl-
-cyclodextrin had no effect on the solubility of EhLimA, while
the cholesterol-complexing agent digitonin resulted in almost
complete solubilization of EhLimA. In a previous study (50), it
was reported that methyl--cyclodextrin was effective in disas-
sociating proteins from detergent-resistant membranes only
when used on homogenates of MDCK cells but not when used
on intact cells. Interestingly, in another study (1), the amount
of proaerolysin, an inactive precursor of the bacterial toxin
aerolysin, in the detergent-insoluble pellet and in the solubi-
lized fraction of BHK cells was only slightly affected by methyl-
-cyclodextrin, while saponin treatment resulted in redistribu-
tion of most of the protein to the detergent-soluble fraction.
These findings indicate that the ability of cholesterol-affecting
agents to disrupt rafts may be highly dependent on the state of
the cells during treatment with these agents and that not all
rafts whose integrity depends on cholesterol will be equally
affected by different cholesterol-affecting agents. In addition,
variations in the lipid composition of different rafts may affect
the protein solubilization properties of cholesterol-depleting
agents. Taken together, the results obtained in the sucrose
gradient flotation assay together with the observation that the
cholesterol-sequestering agent digitonin almost completely
abolishes the Triton X-100 insolubility of EhLimA indicate
that in addition to being associated with the actin cytoskeleton,
a portion of EhLimA may also associate with raft-like microdo-
mains in the plasma membrane.
The observed localization of EhLimA to the plasma mem-
brane of cells can be attributed to both an association of
EhLimA with the underlying cortical actin cytoskeleton and to
some degree with membrane rafts. While association of
EhLimA with the cytoskeleton is mediated through actin bind-
ing and involves the N-terminal LIM domain of EhLimA, the
mechanism responsible for the association of EhLimA with
rafts is not as clear. EhLimA does not possess any known
structural features, such as a glycosylphosphatidylinositol an-
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chor, acyl tails, or a transmembrane domain, that could ac-
count for raft association (52). We have not established
whether the interaction between EhLimA and actin takes
place directly or indirectly, and it is possible that their inter-
action occurs indirectly with an additional protein or proteins
mediating the interaction between the LIM domain of
EhLimA and both actin and lipid rafts. Such proteins may
include actin binding proteins that have the ability to bind
phosphoinositide lipids, such as phosphatidylinositol 4,5-
bisphosphate [PtdIns(4,5)P2] (51), and are thought to link the
actin cytoskeleton with the plasma membrane and in some
cases with rafts. Examples include ERM (ezrin/radixin/moesin)
proteins that can bind to phosphoinositides (41) and are con-
sidered mediators of interactions between the actin cytoskele-
ton and plasma membrane (2, 11, 12). Gelsolin, an actin-
capping and -severing protein that binds to phosphoinositides
has been shown to associate with rafts (22). A different exam-
ple involves the membrane raft protein PAG, which was found
to bind to the cytoplasmic adaptor protein EBP50 (10) that is
known to interact with the ERM-family proteins that bind to
the actin cytoskeleton. In this case, a number of proteins par-
ticipate in connecting membrane rafts to the actin cytoskele-
ton. Similarly, our results suggest that EhLimA may be part of
the molecular system connecting the actin cytoskeleton to
membrane rafts. Since our results show that EhLimA is
cleaved at the N terminus, N-terminal cleavage may serve as a
regulatory mechanism rendering EhLimA unable to associate
with protein partners and thereby affecting its ability to interact
with the cytoskeleton and membrane rafts.
In agreement with the role of the LIM domain as a protein
binding interface, it is conceivable that the LIM domain of
EhLimA serves as a platform for the formation of a multipro-
tein complex that includes proteins possessing both actin bind-
ing capabilities and lipid binding capabilities and that associa-
tion of EhLimA with actin and lipid rafts takes place as part of
this multiprotein complex. While identification of such pro-
teins will be the subject of future work, preliminary results
have identified the glycolytic enzyme enolase as a putative
binding partner of EhLimA. Though generally found in the
cytoplasm, a number of studies have identified -enolase on
the surfaces of many cell types (43). Furthermore, in a recent
study, a small fraction of enolase from the malarial parasite
Plasmodium yoeli was found to be associated with cell mem-
branes and cytoskeletal elements (42). This makes enolase an
interesting candidate for mediating the interactions between
EhLimA and the cytoskeleton and/or lipid rafts.
Our results also show that silencing or overexpression of
EhLimA did not cause any significant effect on the growth or
morphology of the parasite. Since the E. histolytica genome
contains several putative LIM proteins (35), it is possible that
in the absence of EhLimA, other LIM proteins compensate for
its function. In addition, because the amoeba substrain G3 in
which the silencing of a second gene can be induced is already
avirulent, it was not possible to investigate whether EhLimA
plays any role in parasite virulence.
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